1. Home
  2. IMCR vs MSDL Comparison

IMCR vs MSDL Comparison

Compare IMCR & MSDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMCR
  • MSDL
  • Stock Information
  • Founded
  • IMCR 2008
  • MSDL 2019
  • Country
  • IMCR United Kingdom
  • MSDL United States
  • Employees
  • IMCR N/A
  • MSDL N/A
  • Industry
  • IMCR Biotechnology: Biological Products (No Diagnostic Substances)
  • MSDL
  • Sector
  • IMCR Health Care
  • MSDL
  • Exchange
  • IMCR Nasdaq
  • MSDL NYSE
  • Market Cap
  • IMCR 1.7B
  • MSDL 1.8B
  • IPO Year
  • IMCR 2021
  • MSDL N/A
  • Fundamental
  • Price
  • IMCR $32.93
  • MSDL $19.91
  • Analyst Decision
  • IMCR Buy
  • MSDL Buy
  • Analyst Count
  • IMCR 14
  • MSDL 7
  • Target Price
  • IMCR $74.75
  • MSDL $21.67
  • AVG Volume (30 Days)
  • IMCR 267.8K
  • MSDL 407.4K
  • Earning Date
  • IMCR 11-05-2024
  • MSDL 01-01-0001
  • Dividend Yield
  • IMCR N/A
  • MSDL 7.50%
  • EPS Growth
  • IMCR N/A
  • MSDL N/A
  • EPS
  • IMCR N/A
  • MSDL N/A
  • Revenue
  • IMCR $280,914,000.00
  • MSDL N/A
  • Revenue This Year
  • IMCR $25.60
  • MSDL $1,597.39
  • Revenue Next Year
  • IMCR $10.63
  • MSDL $14.28
  • P/E Ratio
  • IMCR N/A
  • MSDL N/A
  • Revenue Growth
  • IMCR 27.95
  • MSDL N/A
  • 52 Week Low
  • IMCR $29.72
  • MSDL $19.05
  • 52 Week High
  • IMCR $76.98
  • MSDL $24.18
  • Technical
  • Relative Strength Index (RSI)
  • IMCR 52.76
  • MSDL 52.37
  • Support Level
  • IMCR $31.10
  • MSDL $19.48
  • Resistance Level
  • IMCR $35.47
  • MSDL $20.39
  • Average True Range (ATR)
  • IMCR 1.49
  • MSDL 0.34
  • MACD
  • IMCR 0.17
  • MSDL 0.02
  • Stochastic Oscillator
  • IMCR 51.98
  • MSDL 69.06

About IMCR Immunocore Holdings plc

Immunocore Holdings PLC is a late-stage biotechnology company engaged in the development of a novel class of TCR bispecific immunotherapies for the treatment of cancer, infectious and autoimmune diseases. Its geographical segments are the United Kingdom and the United States, of which the majority of its revenue comes from the United States.

About MSDL MORGAN STANLEY DIRECT LENDING FUND

Morgan Stanley Direct Lending Fund is a fund whose investment objective is to achieve attractive risk-adjusted returns via current income and, to a lesser extent, capital appreciation by investing predominantly in directly originated senior secured term loans issued by U.S. middle-market companies backed by private equity sponsors. It invests predominantly in directly originated senior secured term loans including first lien senior secured term loans including unitranche loans and second lien senior secured term loans, with the balance of the investments expected to be in higher-yielding assets such as mezzanine debt, unsecured debt, equity investments and other opportunistic asset purchases.

Share on Social Networks: